Appendix G

Institute of Medicine Publications on Vaccines

• Adverse Effects of Vaccines: Evidence and Causality (2012)
• Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint (2012)
• “A Perspective on Vaccines,” President’s Address, Institute of Medicine Annual Meeting, Washington, DC (2011)
• The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series (2010)
• The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2009)
• Live Variola Virus: Considerations for Continuing Research (2009)
• Priorities for the National Vaccine Plan (2009)
• Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office (2008)
• Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Program (2006)
• John R. La Montagne Memorial Symposium on Pandemic Influenza Research: Meeting Proceedings (2006)
• The Smallpox Vaccination Program: Public Health in an Age of Terrorism (2005)
• Vaccine Safety Research, Data Access, and Public Trust (2005)
• Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004)
• Immunization Safety Review: Vaccines and Autism (2004)

• Financing Vaccines in the 21st Century: Assuring Access and Availability (2003)
• Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 1 (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 2 (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 3 (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 4 (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 5 (2003)
• Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 6 (2003)
• Setting the Course—A Strategic Vision for Immunization. Part 3: Summary of the Los Angeles Workshop (2003)
• Setting the Course—A Strategic Vision for Immunization. Part 4: Summary of the Washington, DC, Workshop (2003)
• The Anthrax Vaccine: Is It Safe? Does It Work? (2002)
• An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (2002)
• Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies (2002)
• Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002)
• Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (2002)
• Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (2002)
• Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military (2002)
• Scientific and Policy Considerations in Developing Smallpox Vaccination Options: A Workshop Report (2002)
• Setting the Course—A Strategic Vision for Immunization Finance. Part 1: Summary of the Chicago Workshop (2002)
• Setting the Course—A Strategic Vision for Immunization. Part 2: Summary of the Austin Workshop (2002)
• Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
• Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (2001)

• Statement from the IOM Council on Vaccine Development (2001)
• An Assessment of the Safety of the Anthrax Vaccine: A Letter Report (2000)
• Calling the Shots: Immunization Finance Policies and Practices (2000)
• Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report (2000)
• Vaccines for the 21st Century: A Tool for Decisionmaking (2000)
• Assessment of Future Scientific Needs for Live Variola Virus (1999)
• Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices (1999)
• Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary (1997)
• Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention: Workshop Summary (1997)
• Risk Communication and Vaccination: Workshop Summary (1997)
• Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996)
• Vaccines Against Malaria: Hope in a Gathering Storm (1996)
• The Children’s Vaccine Initiative: Continuing Activities (1995)
• Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality (1994)
• DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis (1994)
• Research Strategies for Assessing Adverse Events Associated with Vaccines: A Workshop Summary (1994)
• The Children’s Vaccine Initiative: Achieving the Vision (1993)
• Adverse Effects of Pertussis and Rubella Vaccines (1991)
• The Potential Value of Research Consortia in the Development of Drugs and Vaccines Against HIV Infection and AIDS (report of a workshop) (1989)
• An Evaluation of Poliomyelitis Vaccine: Policy Options (1988)
• Prospects for Vaccines Against HIV Infection (1988)
• Temperature-Stable Vaccines for Developing Countries: Significance and Development Strategies (1987)
• New Vaccine Development: Establishing Priorities. Volume II, Diseases of Importance in Developing Countries (1986)
• New Vaccine Development: Establishing Priorities. Volume I, Diseases of Importance in the United States (1985)
• Vaccine Supply and Innovation (1985)
• Evaluation of Poliomyelitis Vaccines (1977)

This page is blank